Misplaced Pages

Oxanamide: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 16:21, 29 July 2010 editPotatoBot (talk | contribs)Bots51,239 editsm Stub sorting and placement of stub template(s)← Previous edit Latest revision as of 15:07, 31 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,777 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(21 intermediate revisions by 18 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| verifiedrevid = 421882229
| IUPAC_name = 2-ethyl-3-propyloxirane-2-carboxamide | IUPAC_name = 2-ethyl-3-propyloxirane-2-carboxamide
| image = Oxanamide.png | image = Oxanamide.png
| CAS_number = 126-93-2

| ATC_prefix = none
<!--Clinical data-->
| ATC_suffix =
| tradename =
| PubChem = 31365
| pregnancy_category =
| C = 8 | H = 15 | N = 1 | O = 2
| legal_status =
| molecular_weight = 157.21 g/mol
| routes_of_administration =
| bioavailability =

| metabolism =
<!--Pharmacokinetic data-->
| elimination_half-life =
| bioavailability =
| excretion =
| metabolism =
| pregnancy_category=
| elimination_half-life =
| legal_status =
| excretion =
| routes_of_administration =

<!--Identifiers-->
| CAS_number = 126-93-2
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 050271194T
| ATC_prefix = none
| ATC_suffix =
| PubChem = 31365
| ChemSpiderID = 29098

<!--Chemical data-->
| C=8 | H=15 | N=1 | O=2
| smiles = CCCC1C(O1)(CC)C(=O)N
| StdInChI = 1S/C8H15NO2/c1-3-5-6-8(4-2,11-6)7(9)10/h6H,3-5H2,1-2H3,(H2,9,10)
| StdInChIKey = WBLPIVIXQOFTPQ-UHFFFAOYSA-N

}} }}


'''Oxanamide''' ('''Quiactin''') is an ] and ] which can produce ] and ] effects in sufficiently high doses.<ref>{{cite journal|title=Effects of oxanamide on the central nervous system |journal=Proceedings of the Society for Experimental Biology and Medicine |year=1960 |volume=103 |pages=101–3|pmid=14412594|last1=Kuhn|first1=WL|last2=Ketteler|first2=HJ|last3=Van Maanen|first3=EF}}</ref> An uncontrolled trial on patients treated in a clinical ] practice published in 1959 found that oxanamide was efficacious in the treatment of anxiety resulting from ], ], and various other causes, with minimal sedation or other side effects.<ref>{{cite journal| author=Robert B. Woodhull |title=Oxanamide; adjunctive use of a new tranquilizer in gynecology| journal=California Medicine| year=1959 |volume=90 |issue=4 |pages=275–7 |url=http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1577644&blobtype=pdf| pmid=13638840| pmc=1577644}}</ref> '''Oxanamide''' ('''Quiactin''') is an ] and ] which can produce ] and ] effects in sufficiently high doses.<ref>{{cite journal | vauthors = Kuhn WL, Ketteler HJ, Van Maanen EF | s2cid = 40927309 | title = Effects of oxanamide on the central nervous system | journal = Proceedings of the Society for Experimental Biology and Medicine | volume = 103 | pages = 101–3 | date = January 1960 | pmid = 14412594 | doi = 10.3181/00379727-103-25425 }}</ref> An uncontrolled trial on patients treated in a clinical ] practice published in 1959 found that oxanamide was efficacious in the treatment of anxiety resulting from ], ], and various other causes, with minimal sedation or other side effects.<ref>{{cite journal | vauthors = Woodhull RB | title = Oxanamide; adjunctive use of a new tranquilizer in gynecology | journal = California Medicine | volume = 90 | issue = 4 | pages = 275–7 | date = April 1959 | pmid = 13638840 | pmc = 1577644 }}</ref>


== References == == References ==
{{Reflist|2}} {{Reflist|2}}



{{Anxiolytics}} {{Anxiolytics}}
Line 29: Line 45:
] ]
] ]
] ]
] ]




{{musculoskeletal-drug-stub}} {{musculoskeletal-drug-stub}}
{{nervous-system-drug-stub}} {{Anxiolytic-stub}}
{{Sedative-stub}}